| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.05 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.05 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.16 | 0.05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |